Meloxicam Recruiting Phase 3 Trials for Migraine Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03896009Maximizing Outcomes in Treating Acute Migraine